ALLR

Allarity Therapeutics, Inc.

Healthcare · Biotechnology

$293.30 sample

+5.30 (+1.84%) 1D

Market cap

$1.84T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-08

Alerts

8

Price$293.30 +5.90% 3M daily closessample

296.66262.75

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08SECDEF 14A filed
Oct 02INSInsider sell: Director
Sep 23SEC8-K filed: material event
Sep 18INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: 10% owner
Sep 07SEC10-Q filed
Aug 31INSInsider sell: EVP, Operations
Aug 21SECDEF 14A filed

Sign up to see the real ALLR record →

Company facts

SEC EDGAR registration

Name: Allarity Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in ALLR

sample

Insiders: 29 insider transactions over 90 days, net selling, $247.9M
Congress: 4 members traded over 90 days
Institutions · 13F: 38 funds hold $32.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$65.3B +20.5% y/y

Q4 2024Q3 2026

Inventory$37.3B +7.0% y/y

Q4 2024Q3 2026

Accounts receivable$29.6B +22.8% y/y

Q4 2024Q3 2026

Total debt$75.2B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $852.8B +2.9% 3M
Sample peer B: $642.6B +15.5% 3M
Sample peer C: $1.41T +13.1% 3M
Sample peer D: $1.03T -1.1% 3M
Sample peer E: $917.9B -10.6% 3M